| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
American Journal of Clinical Nutrition, Vol 33, 2041-2052, Copyright © 1980 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
AF Roche and JH Himes
Serial data from 818 normal American white children have been used to construct 6-month increment charts for weight (0 to 18 years), head circumference and recumbent length (0 to 3 years), and stature (2 to 18 years). The attained growth status of these children is very close to that shown in the National Center for Health Statistics charts at all ages. Consequently, the present increment charts are widely applicable; it is expected secular changes will not affect their usefulness in ther near future. The need for accurate anthropometric techniques is emphasized and guides to the interpretation of findings are presented.
This article has been cited by other articles:
|
|
 |
|
  D. K. Benjamin Jr, S. Hirschfeld, C. K. Cunningham, and R. E. McKinney Jr Growth as a part of the composite endpoint in paediatric antiretroviral clinical trials J. Antimicrob. Chemother., October 1, 2004; 54(4): 701 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Mei, L. M. Grummer-Strawn, D. Thompson, and W. H. Dietz Shifts in Percentiles of Growth During Early Childhood: Analysis of Longitudinal Data From the California Child Health and Development Study Pediatrics, June 1, 2004; 113(6): e617 - e627. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Culnane, M. Fowler, S. S. Lee, G. McSherry, M. Brady, K. O'Donnell, L. Mofenson, S. L. Gortmaker, D. E. Shapiro, G. Scott, et al. Lack of Long-term Effects of In Utero Exposure to Zidovudine Among Uninfected Children Born to HIV-Infected Women JAMA, January 13, 1999; 281(2): 151 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Kline, R. B. Van Dyke, J. C. Lindsey, M. Gwynne, M. Culnane, R. E. McKinney Jr, S. Nichols, W. G. Mitchell, R. Yogev, N. Hutcheon, et al. A Randomized Comparative Trial of Stavudine (d4T) Versus Zidovudine (ZDV, AZT) in Children With Human Immunodeficiency Virus Infection Pediatrics, February 1, 1998; 101(2): 214 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Englund, C. J. Baker, C. Raskino, R. E. McKinney, B. Petrie, M. G. Fowler, D. Pearson, A. Gershon, G. D. McSherry, E. J. Abrams, et al. Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected Children N. Engl. J. Med., June 12, 1997; 336(24): 1704 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Clarick, W. A. Hanekom, R. Yogev, and E. G. Chadwick Megestrol Acetate Treatment of Growth Failure in Children Infected With Human Immunodeficiency Virus Pediatrics, March 1, 1997; 99(3): 354 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lampl, N. Cameron, J. D. Veldhuis, and M. L. Johnson Response Science, April 21, 1995; 268(5209): 445 - 447. [PDF]
|
|
|
|
|
|
M Lampl, J. Veldhuis, and M. Johnson Saltation and stasis: a model of human growth Science, October 30, 1992; 258(5083): 801 - 803. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
